STAT+: Dyne Therapeutics plans to file for approval for next-generation Duchenne drug
Dyne Therapeutics announced on Monday that its experimental drug for Duchenne muscular dystrophy has successfully met its goals in a…
STAT+: Kymera drug positioned to rival Sanofi and Regeneron’s Dupixent succeeds in early-stage eczema trial
Stat Kymera Drug Positioned to Challenge Dupixent in Eczema Treatment Kymera Therapeutics announced on Monday that it has once again…
STAT+: Structure reports promising weight loss outcomes with obesity drug, but side effect questions loom
Stat Structure Reports Promising Weight Loss Results with New Obesity Drug Structure Therapeutics announced on Monday that its experimental GLP-1…
STAT+: Early update shows Wave’s RNA drug cut visceral fat
Stat Early Update Shows Wave’s RNA Drug Reduces Visceral Fat Wave Life Sciences recently shared an early update revealing that…
STAT+: Results in Terns leukemia drug study suggest it could be a successor to Novartis blockbuster
Stat Results in Terns Highlight Promising Leukemia Drug Progress Terns Pharmaceuticals shared an important update on Monday regarding its targeted…
STAT+: At ASH, Terns looks like rival to Novartis with drug for chronic myeloid leukemia
STAT at ASH Terns Emerges as a Rival to Novartis in Chronic Myeloid Leukemia Treatment The American Society of Hematology…
STAT+: Hengrui, BeOne top new analysis of Chinese drug development
Stat Hengrui BeOne Top: New Report Highlights Leading Chinese Drug Developers A recent report has shed light on the landscape…
STAT+: New data from Gilead, Arcellx multiple myeloma CAR-T suggest benefit over rival treatment
Stat New Data from Gilead and Arcellx Show Promise for Multiple Myeloma CAR-T Therapy Gilead Sciences is facing challenges as…
STAT+: Fulcrum study suggests improved efficacy for higher dose sickle cell pill
Stat Fulcrum Study Suggests Higher Dose Improves Sickle Cell Treatment Fulcrum Therapeutics announced on Sunday that a higher dose of…
STAT+: Incyte study results suggest a new approach to treating myelofibrosis
Stat Incyte Study Results Show Promise for New Myelofibrosis Treatment Incyte has reported encouraging results from a study involving an…